Scorpion Venom Polypeptide Inhibits Pulmonary Epithelial-Mesenchymal Transition in Systemic Sclerosis-Interstitial Lung Disease Model Mice by Intervening TGF-<i>β</i>1/Smad Signaling Pathway

<div>Immunohistochemical staining of TGF-<i>β</i>1 in the lung tissue of mice in each group (400-fold, scale bar = 50 <i>μ</i>m). NC, normal control group; BLM, bleomycin-induced systemic sclerosis model group; PESV-L, low-dose PESV intervention group; PESV-M, medium-dose PESV intervention group; PESV-H, high-dose PESV intervention group; DXM, dexamethasone intervention group.</div>

Evidence-Based Complementary and Alternative Medicine

fig5

Figure 5

Figure 5: Scorpion Venom Polypeptide Inhibits Pulmonary Epithelial-Mesenchymal Transition in Systemic Sclerosis-Interstitial Lung Disease Model Mice by Intervening TGF-<i>β</i>1/Smad Signaling Pathway 

Figure 5 | Scorpion Venom Polypeptide Inhibits Pulmonary Epithelial-Mesenchymal Transition in Systemic Sclerosis-Interstitial Lung Disease Model Mice by Intervening TGF-β1/Smad Signaling Pathway 